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District Judge: The Honorable Esther Salas 
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  OPINION 
_____________________                              
      
SMITH, Circuit Judge.  
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 Chaya and Menachem Grossbaum (the “Grossbaums”) filed suit against 
Genesis Genetics Institute, LLC, Mark R. Hughes, New York University School of 
Medicine, New York University Hospitals Center, ABC Corps. 1-10, and John 
Does 1-10.1
I. 
  The Grossbaums raise claims on their own behalf, and on behalf of 
their infant daughter, arising out of Defendants’ alleged negligence in testing and 
implanting an embryo containing the mutation for the genetic disorder cystic 
fibrosis.  The District Court, applying New York law, dismissed the Grossbaums’ 
claims as untimely.  For the following reasons, we will affirm. 
 The Grossbaums are both “carriers” of the genetic mutation for cystic 
fibrosis, meaning both of them have one gene with the mutation and one gene 
without the mutation.  Because cystic fibrosis is a recessive disorder, an individual 
needs two genes with the mutation in order to suffer from the disorder; 
consequently, neither of the Grossbaums actually suffers from cystic fibrosis.  
Nevertheless, because they are both carriers, children conceived by them would 
have an approximately one-in-four chance of receiving two genes with the 
mutation, and thus a one-in-four chance of suffering from the disorder. 
 In February 2004, while living in New York, the Grossbaums discussed 
                                                 
1 We refer to defendants Genesis Genetics Institute, LLC and Mark R. Hughes 
collectively as “Genesis.”  We refer to defendants New York University School of 
Medicine and New York University Hospitals Center collectively as “NYU.”   
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having a child.  Aware of the risks, they inquired about a new process known as 
Pre-Implantation Genetic Diagnosis (“PGD”) that might decrease the probability 
that their child would suffer from cystic fibrosis.  PGD required fertilizing several 
of Chaya Grossbaum’s eggs, and testing the resulting embryos for the relevant 
genetic mutation.  One or more embryos that did not appear to have two genes with 
the mutation would then be implanted using in vitro fertilization (“IVF”). 
 In March 2004, the Grossbaums consulted with Defendants about both 
procedures.  Under the proposed arrangement, Genesis would perform the PGD, 
and NYU would perform the IVF.  The Grossbaums agreed to both procedures, 
signing consent forms acknowledging certain attendant risks.  On July 14, 2004, 
Defendants began the procedures in New York by collecting and fertilizing several 
of Chaya Grossbaum’s eggs.  Cells from these embryos were sent to Genesis, 
located in Michigan, to perform the PGD.  On July 19, 2004, Genesis reported to 
NYU that at least three of the embryos did not contain two genes with the mutation 
for cystic fibrosis and were thus safe for implantation.  That same day, after 
discussing the PGD results with the Grossbaums, NYU implanted two of these 
embryos using IVF.  The IVF procedure took place in New York.  NYU monitored 
Chaya Grossbaum’s pregnancy for several weeks after the implantation; all of this 
monitoring took place in New York. 
 Unbeknownst to the Grossbaums and the Defendants, at least one of the 
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implanted embryos had two genes with the mutation for cystic fibrosis.  The 
Grossbaums’ daughter was born in New Jersey on March 25, 2005, and was soon 
thereafter diagnosed with cystic fibrosis.  The Grossbaums filed suit on March 23, 
2007.   
 On January 20, 2011, Genesis and NYU filed separate motions for summary 
judgment.  Genesis argued that New York law should apply, and that the 
Grossbaums’ claims were untimely under N.Y.C.P.L.R. 214-a, which sets out a 
statute of limitations for medical malpractice claims.2
 On June 10, 2011, the District Court ruled on the pending motions for 
summary judgment.  The court first agreed with Genesis that New York law 
  NYU argued that New 
Jersey law should apply, and that the Grossbaums’ claims failed under New Jersey 
law.  In opposition to these motions, the Grossbaums argued only that New Jersey 
law should apply, and that summary judgment was not warranted under New 
Jersey law.  They offered no argument as to whether their complaint was timely 
under Rule 214-a.  In its reply brief, NYU raised the issue of untimeliness under 
New York law, pursuant to Rule 214-a. 
                                                 
2 N.Y.C.P.L.R. 214-a requires that: 
An action for medical, dental or podiatric malpractice must be 
commenced within two years and six months of the act, omission or 
failure complained of or last treatment where there is continuous 
treatment for the same illness, injury or condition which gave rise to 
the said act, omission or failure. 
Id. 
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applied.  The court then considered whether the Grossbaums’ claims were 
untimely under Rule 214-a—an issue raised in Genesis’s brief to which the 
Grossbaums had declined to respond.  The court concluded that the Grossbaums’ 
claims were untimely under Rule 214-a and granted Genesis’s motion for summary 
judgment. 
 The District Court also recognized, however, that NYU had failed to argue 
that the Grossbaums’ claims were untimely under Rule 214-a in their opening 
brief, and had only raised the issue in their reply brief.  Therefore, the court 
declined to grant NYU’s motion for summary judgment and instead requested 
supplemental briefing from the Grossbaums “addressing only NYU Defendants’ 
reply brief arguments that Plaintiffs’ claims fail under New York’s statute of 
limitations and for lack of causation[.]”  App’x A40.   
 On June 29, 2011, the Grossbaums filed their supplemental brief.  This brief 
did not address the argument that the Grossbaums’ claims were untimely under 
Rule 214-a.  Subsequently, the District Court granted NYU’s motion for summary 
judgment, noting that the Grossbaums “failed to advance any arguments relating to 
the statute of limitations as it pertains to the NYU Defendants, other than 
criticizing [the District Court’s] choice of law analysis.”  App’x A42.  The 
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Grossbaums timely appealed.3
III. 
 
 The Grossbaums raise two arguments on appeal concerning the District 
Court’s orders granting Defendants’ motions for summary judgment.4
 First, we agree with the District Court that New York law applies.  A federal 
court sitting in diversity applies the forum state’s choice-of-law rules.  Gen. Star 
Nat’l Ins. Co. v. Liberty Mut. Ins. Co., 960 F.2d 377, 379 (3d Cir. 1992).  If an 
  First, they 
argue that the District Court erred by applying New York law, rather than New 
Jersey law.  Second, they argue for the first time that even if New York law does 
apply, their claims are timely.  Specifically, they argue that the 2.5-year statute of 
limitations in Rule 214-a did not begin to run until March 25, 2005, the date their 
daughter was born.  Thus, they claim, their complaint, filed less than two years 
after their daughter’s birth, was timely.  We review these issues de novo, applying 
the same standard as the District Court.  See Doe v. Luzerne Cnty., 660 F.3d 169, 
174 (3d Cir. 2011). 
                                                 
3 The District Court had diversity jurisdiction over this matter, pursuant to 28 
U.S.C. § 1332.  We have jurisdiction over this appeal pursuant to 28 U.S.C. 
§ 1291. 
 
4 The Grossbaums request that, if we reverse the District Court’s grant of summary 
judgment, we also reverse the court’s ruling on particular discovery matters.  
Because we will affirm the judgment of the District Court, we do not reach these 
arguments. 
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“actual conflict” exists between the laws of jurisdictions with ties to a case, New 
Jersey applies the “most significant relationship” test set forth in the Restatement 
(Second) of Conflict of Laws.  See Lebegern v. Forman, 471 F.3d 424, 428 (3d 
Cir. 2006); P.V. ex rel. T.V. v. Camp Jaycee, 962 A.2d 453, 459-60 (N.J. 2008).  
As the District Court found, an actual conflict exists here:  Michigan bars all 
variations of the claims asserted by the Grossbaums, see Mich. Comp. Laws Ann. 
§ 600.2971, whereas the New Jersey and New York statutes of limitations for 
medical malpractice claims differ in both length and the date on which they begin 
to run, compare N.J. Stat. Ann. § 2A:14-2 (two-year statute of limitations), and 
Caravaggio v. D’Agostini, 765 A.2d 182, 189 (N.J. 2001) (holding that the statute 
of limitations begins to run on the date the alleged malpractice is discovered), with 
N.Y.C.P.L.R. 214-a (30-month statute of limitations running from the act, 
omission, or failure complained of).   
The court also applied the proper legal test for establishing the jurisdiction 
with the “most significant relationship” to the claims, and considered all of the 
relevant factors.  See Camp Jaycee, 962 A.2d at 459-60.  Almost all of the relevant 
events occurred in New York:  the Grossbaums initially consulted with NYU in 
New York, Chaya Grossbaum’s eggs were collected and fertilized in New York, 
NYU spoke with the Grossbaums about the results of the PGD tests in New York, 
the IVF took place in New York, follow-up consultations during the early stages of 
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pregnancy took place in New York, and the Grossbaums lived in New York 
throughout the pregnancy.  Admittedly, the Grossbaums did stay in New Jersey in 
the weeks leading up to their daughter’s birth, and their daughter was actually born 
in New Jersey.  Nonetheless, we agree with the District Court that the weight of the 
relevant factors points towards applying New York law. 
 Second, we conclude that the Grossbaums have waived their argument that 
their claims are timely under Rule 214-a.  “‘Absent exceptional circumstances, this 
Court will not consider issues raised for the first time on appeal.’”  In re Ins. 
Brokerage Antitrust Litig., 579 F.3d 241, 261 (3d Cir. 2009) (quoting Del. Nation 
v. Pennsylvania, 446 F.3d 410, 416 (3d Cir. 2006)).   Such a rule is “‘essential . . . 
[so] that litigants may not be surprised on appeal by final decision there of issues 
upon which they have had no opportunity to introduce evidence.’”  Harris v. City 
of Phila., 35 F.3d 840, 845 (3d Cir. 1994) (quoting Hormel v. Helvering, 312 U.S. 
552, 556 (1941)). 
We may depart from this general rule at our discretion, where “under the 
circumstances it would be just to do so[.]”  Del. Nation, 446 F.3d at 416 n.9.  For 
example, we might consider an issue raised for the first time on appeal “where the 
proper resolution is beyond any doubt, or where injustice might otherwise result.”  
Singleton v. Wulff, 428 U.S. 106, 121 (1976) (internal citations and quotation 
marks omitted).  We have also departed from this rule “where there has been an 
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intervening change in law or the lack of representation by an attorney.”5
 We see no extraordinary circumstances here that would justify departing 
from our general rule in this instance.  The Grossbaums made a tactical choice not 
to respond to Genesis’s argument concerning Rule 214-a, and instead to rely 
completely on their argument against applying New York law.  The District Court 
gave the Grossbaums a second opportunity to raise an argument regarding Rule 
214-a, specifically requesting briefing addressing the argument “that [their] claims 
fail under New York’s statute of limitations[.]”  App’x A40.  Again, they made the 
tactical decision not to contest this issue, despite a specific request from the 
District Court.   
  Del. 
Nation, 446 F.3d at 416 n.9. 
                                                 
5 At oral argument, the Grossbaums suggested that there could be no waiver unless 
they intended to waive the argument.  Such an argument confuses two separate 
types of waiver.  Certainly, for a criminal defendant to waive a constitutional right, 
that waiver must be intentional.  See United States v. Andrews, 681 F.3d 509, 517 
n.4 (3d Cir. 2012) (citing United States v. Olano, 507 U.S. 725, 733 (1993)).  Here, 
the Grossbaums have not waived a constitutional right, but have instead waived an 
argument by failing to raise that argument before the District Court.  See Del. 
Nation, 446 F.3d at 416 & n.9.   A litigant can waive an argument by failing to 
raise the issue before the District Court, even if that litigant did not intend to 
concede the argument.  See id. at 416 (“Although the Delaware Nation now 
contends that it did not concede the argument . . . it does not, and cannot, argue 
that it raised the issue before the District Court.  Therefore, the issue is waived.”  
(citation omitted)).  Even if the Grossbaums were correct, however, they 
intentionally waived their argument here when they were presented with two 
opportunities to raise the argument before the District Court and declined to do so 
for strategic reasons. 
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The Grossbaums’ tactical choice may have been unwise, but it does not 
constitute an exceptional circumstance such that we can overlook their failure to 
raise the argument before the District Court.  Such a result would be particularly 
inappropriate here, “where important and complex issues of law are presented[.]”  
Frank v. Colt Indus., Inc., 910 F.2d 90, 100 (3d Cir. 1990).  We thus hold that the 
Grossbaums have waived their argument that their claims are timely under 
Rule 214-a.  Consequently, we will affirm the District Court’s conclusion that their 
claims are untimely under New York law.6
IV. 
 
For the foregoing reasons, we will affirm the judgment of the District Court. 
 
                                                 
6 Because we conclude that the Grossbaums’ claims are untimely under New York 
law, we need not determine the precise nature of the claims presented in the 
Grossbaums’ complaint—i.e., whether they are “wrongful birth” claims or 
“wrongful life” claims—and whether such claims are cognizable under New York 
law.  Even if the Grossbaums’ claims could be properly characterized as “wrongful 
life” claims, and even if such claims were cognizable under New York law, the 
Grossbaums have waived their argument that such claims were timely under Rule 
214-a. 
 
